These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3776550)
1. In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man. Bäärnhielm C; Dahlbäck H; Skånberg I Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):113-22. PubMed ID: 3776550 [TBL] [Abstract][Full Text] [Related]
2. Biotransformation of felodipine in liver microsomes from rat, dog, and man. Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human. Eriksson UG; Lundahl J; Bäärnhielm C; Regårdh CG Drug Metab Dispos; 1991; 19(5):889-94. PubMed ID: 1686232 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine. Bäärnhielm C; Skånberg I; Borg KO Xenobiotica; 1984 Sep; 14(9):719-26. PubMed ID: 6516445 [TBL] [Abstract][Full Text] [Related]
5. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513 [TBL] [Abstract][Full Text] [Related]
6. Correlation of the intrinsic clearance of donepezil (Aricept) between in vivo and in vitro studies in rat, dog and human. Matsui K; Taniguchi S; Yoshimura T Xenobiotica; 1999 Nov; 29(11):1059-72. PubMed ID: 10598742 [TBL] [Abstract][Full Text] [Related]
7. In vitro to in vivo extrapolation and physiologically based modeling of cytochrome P450 mediated metabolism in beagle dog gut wall and liver. Heikkinen AT; Fowler S; Gray L; Li J; Peng Y; Yadava P; Railkar A; Parrott N Mol Pharm; 2013 Apr; 10(4):1388-99. PubMed ID: 23438212 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation. Obach RS Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851 [TBL] [Abstract][Full Text] [Related]
9. Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man. Bayliss MK; Bell JA; Jenner WN; Park GR; Wilson K Xenobiotica; 1999 Mar; 29(3):253-68. PubMed ID: 10219966 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro kinetics of mofarotene in mouse, rat, dog and man. Vallès B; Ba B; Wyss R; Reigner B; Coassolo P Eur J Drug Metab Pharmacokinet; 1995; 20(1):49-53. PubMed ID: 7588994 [TBL] [Abstract][Full Text] [Related]
11. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse. Weidolf L; Borg KO; Hoffmann KJ Xenobiotica; 1984 Aug; 14(8):657-66. PubMed ID: 6495759 [TBL] [Abstract][Full Text] [Related]
12. Effects of biliary excretion on the disposition of felodipine and metabolites in the rat. Sutfin TA; Gabrielsson M; Regårdh CG Xenobiotica; 1987 Oct; 17(10):1203-14. PubMed ID: 3424867 [TBL] [Abstract][Full Text] [Related]
13. Disposition of the aromatase inhibitor LY56110 and associated induction and inhibition studies in rats, dogs, and monkeys. Lindstrom TD; Whitaker GW Fundam Appl Toxicol; 1987 May; 8(4):595-604. PubMed ID: 3609545 [TBL] [Abstract][Full Text] [Related]
14. Contribution of the intestine to the first-pass metabolism of felodipine in the rat. Wang SX; Sutfin TA; Bäärnhielm C; Regårdh CG J Pharmacol Exp Ther; 1989 Aug; 250(2):632-6. PubMed ID: 2760845 [TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL. Kamath AV; Wang J; Lee FY; Marathe PH Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625 [TBL] [Abstract][Full Text] [Related]
16. A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. Buters JT; Schiller CD; Chou RC Biochem Pharmacol; 1993 Nov; 46(9):1577-84. PubMed ID: 8240414 [TBL] [Abstract][Full Text] [Related]
17. Interspecies variability and drug interactions of clozapine metabolism by microsomes. Bun H; Disdier B; Aubert C; Catalin J Fundam Clin Pharmacol; 1999; 13(5):577-81. PubMed ID: 10520731 [TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
19. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs. Nishimuta H; Houston JB; Galetin A Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071 [TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of the dog hepatic cytochrome P-450 isozyme responsible for the metabolism of 2,2',4,4',5,5'-hexachlorobiphenyl. Duignan DB; Sipes IG; Leonard TB; Halpert JR Arch Biochem Biophys; 1987 Jun; 255(2):290-303. PubMed ID: 3109323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]